Cordova Ashley — SEC Form 4 filings
SEC reporting owner CIK 1822014. 12 Form 4 filings on record with FilingPulse; latest filed 2026-03-05.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-02-29 to 2026-03-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 81,550 shares, $996,859 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 8 legs across 4 filings — 29,729 shares, $584,165 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: purchase of 81,550 shares @ $12.22 ($996,859) in NovoCure Ltd, filed 2025-09-08.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| NovoCure Ltd (NVCR) | Former Chief Executive Officer | 12 | 1 leg · 81,550 sh · $996,859 | 8 legs · 29,729 sh · $584,165 | 12 |
Form 4 filings — Cordova Ashley
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-05 | 4 | NovoCure Ltd (NVCR) | Tax withholding (F): 17,638 @ $13.30 | EDGAR |
| 2026-03-03 | 4 | NovoCure Ltd (NVCR) | Tax withholding (F): 11,541 @ $13.75 · Grant/award (A): 23,818 @ $0 · Tax withholding (F): 2,410 @ $13.67 · Tax withholding (F): 7,228 @ $13.67 | EDGAR |
| 2025-09-08 | 4 | NovoCure Ltd (NVCR) | Purchase (P): 81,550 @ $12.22 | EDGAR |
| 2025-07-01 | 4 | NovoCure Ltd (NVCR) | Grant/award (A): 833 @ $15.13 | EDGAR |
| 2025-03-06 | 4 | NovoCure Ltd (NVCR) | Grant/award (A): 151,181 @ $18.19 · Grant/award (A): 224,123 (derivative) @ $18.19 | EDGAR |
| 2025-03-04 | 4 | NovoCure Ltd (NVCR) | Sale (S): 2,053 @ $18.54 | EDGAR |
| 2025-03-03 | 4/A | NovoCure Ltd (NVCR) | Sale (S): 9,345 @ $19.92 · Sale (S): 1,808 @ $20.55 · Sale (S): 2,341 @ $18.28 | EDGAR |
| 2025-03-03 | 4 | NovoCure Ltd (NVCR) | Sale (S): 9,345 @ $19.92 · Sale (S): 1,808 @ $20.55 · Sale (S): 2,341 @ $18.28 | EDGAR |
| 2025-01-03 | 4 | NovoCure Ltd (NVCR) | Grant/award (A): 373 @ $14.75 | EDGAR |
| 2024-08-06 | 4 | NovoCure Ltd (NVCR) | Grant/award (A): 1,286 @ $12.24 | EDGAR |
| 2024-08-05 | 4 | NovoCure Ltd (NVCR) | Sale (S): 688 @ $20.14 | EDGAR |
| 2024-02-29 | 4 | NovoCure Ltd (NVCR) | Grant/award (A): 102,249 @ $16.30 · Grant/award (A): 156,348 (derivative) @ $16.30 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1822014 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →